Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MYH1 Inhibitors

Common MYH1 Inhibitors include, but are not limited to (S)-(-)-Blebbistatin CAS 856925-71-8, ML-7 hydrochloride CAS 110448-33-4, ML-9 CAS 105637-50-1, Y-27632, free base CAS 146986-50-7 and H-1152 dihydrochloride CAS 451462-58-1.

MYH1 inhibitors belong to a distinct chemical class of compounds designed to target the MYH1 protein, which is a specific isoform of the myosin heavy chain present in muscle tissues. Myosin heavy chains are essential components of the motor protein myosin, responsible for generating muscle contractions and facilitating various types of movement in the body. These inhibitors are designed to interfere with the function of MYH1 and may impact muscle contractility and other physiological processes that rely on MYH1 activity. The underlying mechanisms of MYH2 inhibition can vary among compounds within this class. Some inhibitors directly interact with the MYH1 protein, disrupting its enzymatic activity or actin-binding capabilities, which are essential for the contractile function of myosin. Others may affect regulatory factors involved in MYH1-mediated muscle contraction.

Researchers explore MYH1 inhibitors to gain insights into the fundamental processes of muscle biology and understand the intricacies of MYH1's role in muscle contraction and movement. The study of these inhibitors provides valuable information about myosin motor function and the complex interplay between myosin heavy chains and actin filaments during the muscle contraction process. Furthermore, MYH1 inhibitors serve as essential tools in cell biology and molecular research, aiding scientists in elucidating the molecular pathways that govern muscle contraction and its regulation. These compounds offer valuable experimental opportunities to investigate MYH1's involvement in various physiological and cellular processes, contributing to a comprehensive understanding of muscle function and related biological phenomena. As research in this area continues to evolve, the implications and applications of MYH1 inhibitors are subjects of ongoing investigation. The insights gained from these studies contribute to the broader knowledge of muscle biology and may pave the way for future discoveries and advancements in various scientific fields, including biophysics and chemistry.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$179.00
$307.00
$455.00
$924.00
$1689.00
7
(1)

Blebbistatin specifically inhibits myosin II ATPase activity. This compound binds to the ATPase site of myosin, thereby preventing its interaction with actin and subsequently blocking muscle contraction.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 is a Rho-associated protein kinase (ROCK) inhibitor. ROCK is involved in the regulation of myosin light chain phosphorylation, and its inhibition can decrease myosin activity.

H-1152 dihydrochloride

451462-58-1sc-203592
sc-203592A
1 mg
5 mg
$102.00
$357.00
7
(1)

H-1152 is another potent ROCK inhibitor. By inhibiting ROCK, it indirectly impacts the phosphorylation state of myosin light chain and, hence, its activation.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$92.00
$182.00
71
(2)

H-89 is an inhibitor of protein kinase A (PKA). PKA can phosphorylate and regulate various proteins involved in the myosin activation pathway.

Gö 6976

136194-77-9sc-221684
500 µg
$223.00
8
(1)

Gö 6976 is a protein kinase C (PKC) inhibitor. PKC plays a role in myosin light chain phosphorylation, and its inhibition can affect myosin activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP-600125 is a selective JNK inhibitor. The JNK pathway has links to cellular processes related to muscle contraction and myosin activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). PI3K pathways can regulate various proteins that indirectly influence myosin activity.